EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

COVID‐19 Vaccine Safety in Pregnancy, A Nested Case–Control Study in Births From April 2021 to March 2022, England

Anna A Mensah iD, Julia Stowe, Jennifer E Jardine iD, Freja C M Kirsebom, Tom Clare iD, Meaghan Kall, Helen Campbell, Jamie Lopez-Bernal, Nick Andrews

BJOG: An International Journal of Obstetrics & Gynaecology · 2024

DOI: 10.1111/1471-0528.17949 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2024. Verfasst von Anna A Mensah und 8 weiteren Autor:innen. Beteiligte Einrichtung: UK Health Security Agency, London, UK. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19, SARS-CoV-2, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Assessment of COVID‐19 vaccine safety in pregnancy using population‐based data.

Design

Matched case–control study nested in a retrospective cohort.

Setting

April 2021–March 2022, England. Population or Sample All pregnant individuals aged between 18 and 50 years with valid health records.

Methods

Individuals identified from the national Maternity Services Data Set (MSDS) had their records linked to hospital admission, national COVID‐19 vaccine and COVID‐19 testing databases. Matching included participant's age and estimated week of conception. We compared outcomes across multiple COVID‐19 vaccine exposures using conditional multivariable logistic regression, adjusting for demographic and health characteristics. Main Outcome Measures Adverse pregnancy, maternal and neonatal outcomes.

Results

514 013 individuals were included. We found lower odds of giving birth to a baby who was low birthweight (aOR = 0.86, 95% CI: 0.79–0.93), preterm (aOR = 0.89, 95% CI: 0.85–0.92) or who had an Apgar score < 7 at 5 min of age (aOR = 0.89, 95% CI: 0.80–0.98) for individuals who received at least one dose of COVID‐19 vaccine during pregnancy. The odds of admission to intensive care unit during pregnancy were lower in those vaccinated (aOR = 0.85, 95% CI: 0.76–0.95). There was no association between vaccination in pregnancy and stillbirth, neonatal death, perinatal death and maternal venous thromboembolism in pregnancy.

Conclusions

COVID‐19 vaccines are safe to use in pregnancy. Our findings generated important information to communicate to pregnant individuals and health professionals to support COVID‐19 maternal vaccination programmes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCOVID-19SARS-CoV-2Pregnancy Complications, InfectiousPregnancy OutcomeHumansFemalePregnancyEnglandCase-Control StudiesAdultInfant, NewbornRetrospective StudiesYoung AdultAdolescentPremature BirthMiddle AgedInfant, Low Birth Weight

Stichwörter der Autor:innen

COVID‐19neonatal outcomespregnancyvaccine safety

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • UK Health Security Agency, London, UK.
  • Women's Health Research Unit, Centre for Public Health and Policy, Queen Mary University of London, London, UK.
  • NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London, London, UK.
  • NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, UK.

ORCID-Profile: Anna A Mensah, Jennifer E Jardine, Tom Clare

Zitieren

APA

Mensah, A. A., Stowe, J., Jardine, J. E., Kirsebom, F. C. M., Clare, T., Kall, M., Campbell, H., Lopez-Bernal, J., & Andrews, N. (2024). COVID‐19 Vaccine Safety in Pregnancy, A Nested Case–Control Study in Births From April 2021 to March 2022, England. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.17949

Vancouver

Mensah AA, Stowe J, Jardine JE, Kirsebom FCM, Clare T, Kall M, et al. COVID‐19 Vaccine Safety in Pregnancy, A Nested Case–Control Study in Births From April 2021 to March 2022, England. BJOG: An International Journal of Obstetrics & Gynaecology. 2024. doi:10.1111/1471-0528.17949

BibTeX
@article{Mensah2024,
  author = {Mensah, Anna A and Stowe, Julia and Jardine, Jennifer E and Kirsebom, Freja C M and Clare, Tom and Kall, Meaghan and Campbell, Helen and Lopez-Bernal, Jamie and Andrews, Nick},
  title = {COVID‐19 Vaccine Safety in Pregnancy, A Nested Case–Control Study in Births From April 2021 to March 2022, England},
  journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
  year = {2024},
  doi = {10.1111/1471-0528.17949}
}
Kostenlos starten →